Literature DB >> 28410008

Randomized Clinical Trials on Deep Carious Lesions: 5-Year Follow-up.

L Bjørndal1, H Fransson2, G Bruun1, M Markvart1, M Kjældgaard3, P Näsman3, A Hedenbjörk-Lager2, I Dige4, M Thordrup4.   

Abstract

Deep caries presents a dilemma in terms of which treatment that will render an optimal prognosis by maintaining pulp vitality with absence of apical pathology. Previously, 2 randomized clinical trials were performed testing the short-term effects of stepwise carious tissue removal versus nonselective carious removal to hard dentin with or without pulp exposure. The aim of this article was to report the 5-y outcome on these previously treated patients having radiographically well-defined carious lesions extending into the pulpal quarter of the dentin but with a well-defined radiodense zone between the carious lesion and the pulp. In this long-term study, 239 of 314 (76.2%) patients were analyzed. The stepwise removal group had a significantly higher proportion of success (60.2%) at 5-y follow-up compared with the nonselective carious removal to hard dentin group (46.3%) ( P = 0.031) when pulp exposures per se were included as failures. Pulp exposure rate was significantly lower in the stepwise carious removal group (21.2% vs. 35.5%; P = 0.014). Irrespective of pulp exposure status, the difference (13.3%) was still significant when sustained pulp vitality without apical radiolucency and unbearable pain was considered (95% confidence interval, 3.1-26.3, P = 0.045). After pulp exposure, only 9% ( n = 4) of the analyzed patients were assessed as successful, indicating that the prognosis is highly dubious following conventional pulp-capping procedures (direct pulp capping or partial pulpotomy) in deep carious lesions in adults. In conclusion, the stepwise carious removal group had a significantly higher proportion of pulps with sustained vitality without apical radiolucency versus nonselective carious removal of deep carious lesions in adult teeth at 5-y follow-up ( ClinicalTrials.gov NCT00187837 and NCT00187850).

Entities:  

Keywords:  caries treatment; clinical outcomes; clinical studies; dentin; endodontics; operative dentistry

Mesh:

Year:  2017        PMID: 28410008     DOI: 10.1177/0022034517702620

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  20 in total

1.  Dentists' practice patterns of treatment for deep occlusal caries: Findings from a dental practice-based research network.

Authors:  Naoki Kakudate; Yoko Yokoyama; Futoshi Sumida; Yuki Matsumoto; Valeria V Gordan; Gregg H Gilbert
Journal:  J Dent       Date:  2019-03-29       Impact factor: 4.379

2.  Cytotoxicity and dentin composition alterations promoted by different chemomechanical caries removal agents: A preliminary in vitro study.

Authors:  Fernanda-Rodrigues Guedes; Jéssica-Fernanda-Sena Bonvicini; Gabriela-Leite de Souza; Washington-Henrique-Themoteo da Silva; Camilla-Christian-Gomes Moura; Luiz-Renato Paranhos; Ana-Paula Turrioni
Journal:  J Clin Exp Dent       Date:  2021-08-01

3.  Does the heat generated by fluorescence-aided caries excavation system effect the pulp temperature of primary teeth irreversibly? An in-vitro evaluation of the temperature changes in the pulp chamber.

Authors:  Merve Aksoy; Selin Şen; Arife Kaptan; Çiğdem Büyükkok; Firdevs Tulga-Öz
Journal:  J Clin Exp Dent       Date:  2021-11-01

4.  Biological response to self-etch adhesive after partial caries removal in rats.

Authors:  Adriana Fernandes Da Silva; Marcelo Rocha Marques; Wellington Luiz De Oliveira Da Rosa; Sandra Beatriz Chaves Tarquinio; Pedro Luiz Rosalen; Silvana Pereira Barros
Journal:  Clin Oral Investig       Date:  2018-01-29       Impact factor: 3.573

5.  Resveratrol represses tumor necrosis factor α/c-Jun N-terminal kinase signaling via autophagy in human dental pulp stem cells.

Authors:  Feng-Ming Wang; Zhiai Hu; Xiaohua Liu; Jian Q Feng; Robert A Augsburger; James L Gutmann; Gerald N Glickman
Journal:  Arch Oral Biol       Date:  2018-10-22       Impact factor: 2.633

6.  Influence of selective immunosuppressive drug regimens on the healing of exposed dogs' dental pulp capped with a recent calcium silicate-based cement.

Authors:  Hanan A Soliman; Radwa Ibrahim El-Toukhy; Mona Mohsen Ebrahim; Mohammed E Grawish; Mohamed Abdel Kader Sobh; Salah Hasab Mahmoud
Journal:  Clin Oral Investig       Date:  2021-08-09       Impact factor: 3.573

7.  Selective Caries Removal in Permanent Teeth (SCRiPT) for the treatment of deep carious lesions: a randomised controlled clinical trial in primary care.

Authors:  Jan E Clarkson; Craig R Ramsay; David Ricketts; Avijit Banerjee; Chris Deery; Thomas Lamont; Dwayne Boyers; Zoe Marshman; Beatriz Goulao; Katie Banister; David Conway; Bhupinder Dawett; Sarah Baker; Andrea Sherriff; Linda Young; Marjon van der Pol; Graeme MacLennan; Ruth Floate; Hazel Braid; Patrick Fee; Mark Forrest; Jill Gouick; Fiona Mitchell; Ekta Gupta; Riz Dakri; Jennifer Kettle; Tina McGuff; Katharine Dunn
Journal:  BMC Oral Health       Date:  2021-07-09       Impact factor: 2.757

8.  Interventions for treating cavitated or dentine carious lesions.

Authors:  Falk Schwendicke; Tanya Walsh; Thomas Lamont; Waraf Al-Yaseen; Lars Bjørndal; Janet E Clarkson; Margherita Fontana; Jesus Gomez Rossi; Gerd Göstemeyer; Colin Levey; Anne Müller; David Ricketts; Mark Robertson; Ruth M Santamaria; Nicola Pt Innes
Journal:  Cochrane Database Syst Rev       Date:  2021-07-19

9.  Synthetic Light-Curable Polymeric Materials Provide a Supportive Niche for Dental Pulp Stem Cells.

Authors:  Kyle H Vining; Jacob C Scherba; Alaina M Bever; Morgan R Alexander; Adam D Celiz; David J Mooney
Journal:  Adv Mater       Date:  2017-12-07       Impact factor: 32.086

Review 10.  Cytotoxicity and Bioactivity of Dental Pulp-Capping Agents towards Human Tooth-Pulp Cells: A Systematic Review of In-Vitro Studies and Meta-Analysis of Randomized and Controlled Clinical Trials.

Authors:  Mariano S Pedano; Xin Li; Kumiko Yoshihara; Kirsten Van Landuyt; Bart Van Meerbeek
Journal:  Materials (Basel)       Date:  2020-06-12       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.